Position in PRGO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,975,012
+$1,877,755 QoQ
Shares Held
277,003
+251.4% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Dec 31, 2023CallValue
$370,070
CallShares
11,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $92,308,096 across 12 Drug Manufacturers - Specialty & Generic names. PRGO ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
48,964 | $29,034,672 | |
| 2 | ZTS |
Zoetis Inc.
|
190,415 | $22,508,957 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
149,631 | $19,712,387 | |
| 4 | ALKS |
Alkermes plc.
|
243,043 | $8,594,000 | |
| 5 | HLN |
Haleon plc
|
421,051 | $4,214,720 | |
| 6 | PRGO |
PERRIGO Co plc
This page
|
277,003 | $2,975,012 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
29,715 | $1,535,968 | |
| 8 | LQDA |
Liquidia Corp
|
34,222 | $1,291,538 |
All Filings in PRGO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,975,012 | 277,003 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,097,257 | 78,826 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $822,462 | 31,990 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,624,004 | 61,914 | Shares | Sole | 2024-11-13 | |
| 2023-12-31 | $370,070 | 11,500 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $1,307,215 | 40,622 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $1,331,586 | 39,222 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $698,353 | 19,469 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $672,391 | 19,724 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $599,159 | 16,802 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,693,594 | 41,745 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,039,287 | 53,065 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,625,280 | 41,781 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||